Education
Welcome to Urology Perspectives, a new educational initiative from Arquer Diagnostics, designed specifically for urologists by urologists.
It is an interactive programme that will crowdsource opinions and perspectives of leading urologists across the globe and discuss the latest hot topics, issues and research in bladder cancer.
If you missed the educational events, the full recordings are available below to watch on demand.
MAR | APR | MAY | JUNE | JUL | AUG | SEP | OCT | NOV | DEC
October 2021: VLOG
Join Professor Juan Palou Redorta, Chairman of the Urology Department, Fundacio Puigvert,Barcelona, as he shares his experience of where ultrasound fits into the bladder cancer diagnostic pathway.
He discusses whether combining it with biomarkers could be an effective option in primary diagnosis and recurrence monitoring, reducing the need for unnecessary cystoscopies.
Joan Palou Redorta, MD, PhD, is Professor of Urology at the Universitat Autónoma de Barcelona, Spain and Chairman of Urology Department at the famous Fundació Puigvert in Barcelona, dedicated to Uro-oncology for more than 20 years. He is a world-renowned expert in bladder cancer. He is an expert in laparoscopy and robotic surgery belonging to a cooperative group in robotic radical cystectomy. He has been involved in writing the EAU Guidelines for non-muscle invasive bladder cancer and upper urinary tract tumours and published many chapters in medical and urology books as well as published more than 250 articles in peer-reviewed journals (h-index 61). Among many others, he is a member of the Spanish Urological Association, European Association of Urology (EAU), American Urological Association and Société International d’Urologie. He is involved in the organisation of many educational activities and responsible of the Education of urologists in Europe as a Director of the European School of Urology. He participates in International congresses, courses and symposia, as well as being investigator in many national and international clinical trials.
Thank you for being part of our webinar.
Please use this form to send your questions, comments or feedback to us, along with any ideas for topics on future webinars, vlogs or case studies you’d like to discuss.
July 2021: VLOG
Hear Professor Paolo Gontero discuss the pros and cons of blue light and white light cystoscopy as a bladder cancer diagnostic and also the role new urinary biomarkers can play.
Paolo Gontero holds the position of Full Professor of Urology at the University of Torino School of Medicine and Chairman of the Division of Urology, San Giovanni Battista Hospital (Molinette), Torino, Italy.
His main clinical interests are in the field of Surgical Uro-Oncology, devoted to Robotic and Laparoscopic oncological surgery of bladder, prostate and kidney cancers. He has strong expertise in minimally invasive live donor nephrectomy and reconstructive surgery of transplanted kidney.
He has authored and co-authored more than 350 publications in international journals (main interest in non-muscle invasive bladder cancer and prostate cancer). He is involved in international trials and working groups on the development of new diagnostic and therapeutic modalities for bladder and prostate cancer. He is a panel member of the European Guidelines for non-muscle invasive bladder cancer.
Thank you for being part of our webinar.
Please use this form to send your questions, comments or feedback to us, along with any ideas for topics on future webinars, vlogs or case studies you’d like to discuss.
May 2021: Webinar Q&A VLOG
Professors Ashish Kamat & Morgan Roupret return to answer questions raised during our last webinar exploring the challenges, obstacles and opportunities faced by bladder cancer patients and their urology teams through diagnosis and monitoring.
Ashish M. Kamat is a Professor (Tenure) of Urology and Director of Urologic Oncology Fellowship at MD Anderson Cancer Center, and a graduate of the AUA Leadership Program. His expertise is in multidisciplinary management of urologic cancers with an emphasis on bladder and prostate cancer, organ sparing therapies, minimally invasive techniques, and orthotopic bladder substitution (neobladder). He maintains an active research portfolio in particular in identifying predictors of response to therapy – especially immunotherapy – as a first step towards personalized cancer therapeutics. A major focus of his laboratory research is to develop novel treatments for bladder cancer and identify resistance mechanisms and ways to overcome them. He serves as project PI on the MD Anderson Cancer Center GU (Bladder) SPORE. He has authored over 200 publications, editorials & book chapters in prestigious journals; currently co President of the International Bladder Cancer Network, Chair of the Bladder Cancer Task Force for SITC he serves on the board of regional and national societies for Urology.
Morgan Rouprêt is currently full Professor (academic position) at AP-HP Sorbonne University, in the Academic Urology Department of the Pitié-Salpêtrière Hospital, in Paris, France. He is particularly involved in the field of onco-urology and practices minimally invasive surgery and robot-assisted laparoscopic procedures. From 2019, he has been appointed as chairman of the European Section of Onco-Urology (ESOU) of the EAU. Prof. Rouprêt has a PhD in the field of onco-urology and genetic marker. He is a committed researcher and writer (i.e. over 740 so far) in international, peer-reviewed journals. He focuses and writes on urological cancers particularly upper urinary tract tumours and prostate cancer. In addition, he is the main author or co-author of several books for medical students dedicated to education in the field of urology. He is also member of the Editorial Board of the World Journal of Urology.
Thank you for being part of our webinar.
Please use this form to send your questions, comments or feedback to us, along with any ideas for topics on future webinars, vlogs or case studies you’d like to discuss.
March 2021: Webinar
Join an international panel of renowned uro-oncologists to delve into patient research, commissioned by Arquer Diagnostics, exploring the challenges, obstacles and opportunities faced by bladder cancer patients and their urology teams through diagnosis and recurrence monitoring.
Ashish M. Kamat is a Professor (Tenure) of Urology and Director of Urologic Oncology Fellowship at MD Anderson Cancer Center, and a graduate of the AUA Leadership Program. His expertise is in multidisciplinary management of urologic cancers with an emphasis on bladder and prostate cancer, organ sparing therapies, minimally invasive techniques, and orthotopic bladder substitution (neobladder). He maintains an active research portfolio in particular in identifying predictors of response to therapy – especially immunotherapy – as a first step towards personalized cancer therapeutics. A major focus of his laboratory research is to develop novel treatments for bladder cancer and identify resistance mechanisms and ways to overcome them. He serves as project PI on the MD Anderson Cancer Center GU (Bladder) SPORE. He has authored over 200 publications, editorials & book chapters in prestigious journals; currently co President of the International Bladder Cancer Network, Chair of the Bladder Cancer Task Force for SITC he serves on the board of regional and national societies for Urology.
Morgan Rouprêt is currently full Professor (academic position) at AP-HP Sorbonne University, in the Academic Urology Department of the Pitié-Salpêtrière Hospital, in Paris, France. He is particularly involved in the field of onco-urology and practices minimally invasive surgery and robot-assisted laparoscopic procedures. From 2019, he has been appointed as chairman of the European Section of Onco-Urology (ESOU) of the EAU. Prof. Rouprêt has a PhD in the field of onco-urology and genetic marker. He is a committed researcher and writer (i.e. over 740 so far) in international, peer-reviewed journals. He focuses and writes on urological cancers particularly upper urinary tract tumours and prostate cancer. In addition, he is the main author or co-author of several books for medical students dedicated to education in the field of urology. He is also member of the Editorial Board of the World Journal of Urology.
Dr Giancarlo Marra is a Urological surgeon working in Paris, France. He is currently undertaking a PhD in Prostate Cancer at the University of Turin, Italy. During the few last years he trained in different countries including UK, Italy and France. His main expertise is in the field of Uro-oncology, with a dedicated focus on Prostate Cancer. He is co-author of more than 60 peer reviewed publications and is an active reviewer for the major urological journals. Dr Marra has been a presenter and an invited speaker at several national and international congresses, including Europe, China and the US.
Janet Kukreja is an Assistant Professor, Urologic Oncologist at University of Colorado Anschutz Medical Campus. She has particular interest in the treatment of urologic cancers including bladder, prostate, kidney, testicular, penile and ureteral cancers. She is a member of many national and international societies, including the International Bladder Cancer Network and the National Society of Women in Urology. She is a reviewer for Journal of Urology and BJU International, editorial board member of Journal of Urology and consulting editor of British Journal of Urology International Compass.
